CRBU - Caribou Bioscience GAAP EPS of -$0.46 misses by $0.05 revenue of $2.43M beats by $0.01M
2024-05-07 17:46:38 ET
More on Caribou Bioscience
- Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value
- Caribou Biosciences received IND clearance from FDA for its lupus treatment
- Caribou Bioscience GAAP EPS of -$0.39 in-line, revenue of $3.56M misses by $1.05M
- Seeking Alpha’s Quant Rating on Caribou Bioscience
- Historical earnings data for Caribou Bioscience